Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group

No standard criteria exist for assessing response and progression in clinical trials involving patients with meningioma, and there is no consensus on the optimal endpoints for trials currently under way. As a result, there is substantial variation in the design and response criteria of meningioma tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Huang, Raymond Y, Bi, Wenya Linda, Weller, Michael, Kaley, Thomas, Blakeley, Jaishri, Dunn, Ian, Galanis, Evanthia, Preusser, Matthias, McDermott, Michael, Rogers, Leland, Raizer, Jeffrey, Schiff, David, Soffietti, Riccardo, Tonn, Jörg-Christian, Vogelbaum, Michael, Weber, Damien, Reardon, David A, Wen, Patrick Y
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Reviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6303427/
https://ncbi.nlm.nih.gov/pubmed/30137421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados